In older patients with AF, low-dose edoxaban reduced stroke or systemic embolism without increasing major bleeding

Daniel I Steinberg

doi:10.7326/ACPJ202101190-005

In older patients with AF, low-dose edoxaban reduced stroke or systemic embolism without increasing major bleeding

Ann Intern Med. 2021 Jan;174(1):JC5. doi: 10.7326/ACPJ202101190-005. Epub 2021 Jan 5.

Author

Daniel I Steinberg¹

Affiliation

¹ Icahn School of Medicine at Mount Sinai, New York, New York, USA (D.I.S.).

PMID: 33395333
DOI: 10.7326/ACPJ202101190-005

Abstract

Okumura K, Akao M, Yoshida T, et al. Low-dose edoxaban in very elderly patients with atrial fibrillation. N Engl J Med. 2020;383:1735-45. 32865374.

Publication types

Comment

MeSH terms

Aged
Anticoagulants / adverse effects
Atrial Fibrillation* / complications
Atrial Fibrillation* / drug therapy
Embolism*
Humans
Pyridines
Stroke* / prevention & control
Thiazoles
Treatment Outcome

Substances

Anticoagulants
Pyridines
Thiazoles
edoxaban